Found: 22
Select item for more details and to access through your institution.
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 772, p. 1, doi. 10.1126/scitranslmed.adn0396
- By:
- Publication type:
- Article
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 12, p. 1, doi. 10.1093/ofid/ofad598
- By:
- Publication type:
- Article
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double–Blind Trial.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 5, p. 1, doi. 10.1093/ofid/ofad211
- By:
- Publication type:
- Article
Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors.
- Published in:
- BMC Genomics, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s12864-019-6344-3
- By:
- Publication type:
- Article
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Elevated serum IgA following vaccination against SARS-CoV-2 in a cohort of high-risk first responders.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-19095-7
- By:
- Publication type:
- Article
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.845417
- By:
- Publication type:
- Article
Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4<sup>+</sup> hemangiocytes.
- Published in:
- Nature Medicine, 2006, v. 12, n. 5, p. 557, doi. 10.1038/nm1400
- By:
- Publication type:
- Article
Autoimmunity and tumor immunity induced by immune responses to mutations in self.
- Published in:
- Nature Medicine, 2006, v. 12, n. 2, p. 198, doi. 10.1038/nm1363
- By:
- Publication type:
- Article
Functional Heterogeneity of the Bone Marrow Vascular Niche.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1176, n. 1, p. 47, doi. 10.1111/j.1749-6632.2009.04964.x
- By:
- Publication type:
- Article
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39292-w
- By:
- Publication type:
- Article
Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0060357
- By:
- Publication type:
- Article
A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 2, p. 247, doi. 10.1007/s00262-017-2081-0
- By:
- Publication type:
- Article
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. e2225411, doi. 10.1001/jamanetworkopen.2022.25411
- By:
- Publication type:
- Article
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. 1, doi. 10.1001/jamanetworkopen.2022.25411
- By:
- Publication type:
- Article
Tyrosine kinase receptor RON in human pancreatic cancer: Expression, function, and validation as a target.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 6, p. 1030, doi. 10.1002/cncr.22490
- By:
- Publication type:
- Article
Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice.
- Published in:
- Cancer (0008543X), 2000, v. 89, n. 1, p. 74, doi. 10.1002/1097-0142(20000701)89:1<74::AID-CNCR11>3.0.CO;2-K
- By:
- Publication type:
- Article
The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 7, p. 1519, doi. 10.1002/ijc.21865
- By:
- Publication type:
- Article
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 1, p. 23, doi. 10.1093/infdis/jiac320
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39681-7
- By:
- Publication type:
- Article